Next Article in Journal
Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience
Next Article in Special Issue
SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)
Previous Article in Journal
Influenza and Universal Vaccine Research in China
Previous Article in Special Issue
Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and Pipeline
 
 
Communication

Article Versions Notes

Viruses 2023, 15(1), 119; https://doi.org/10.3390/v15010119
Action Date Notes Link
article pdf uploaded. 30 December 2022 16:22 CET Version of Record https://www.mdpi.com/1999-4915/15/1/119/pdf-vor
article xml file uploaded 11 January 2023 07:54 CET Original file -
article xml uploaded. 11 January 2023 07:54 CET Update https://www.mdpi.com/1999-4915/15/1/119/xml
article pdf uploaded. 11 January 2023 07:54 CET Updated version of record https://www.mdpi.com/1999-4915/15/1/119/pdf
article html file updated 11 January 2023 07:55 CET Original file -
article html file updated 5 March 2023 02:02 CET Update https://www.mdpi.com/1999-4915/15/1/119/html
Back to TopTop